IMAX Corporation (IMAX - Free Report) is set to report fourth-quarter 2018 results on Feb 26.
Notably, the company’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, delivering average positive surprise of 34.6%. In the last reported quarter, the company’s adjusted earnings outpaced the Zacks Consensus Estimate by 3 cents.
Moreover, IMAX’s top line beat the consensus mark in three of the trailing four quarters. In third-quarter 2018, revenues came in at $82.1 million, beating the Zacks Consensus Estimate of $80 million. However, revenues declined 16.9% from the year-ago quarter.
The Zacks Consensus Estimate for fourth-quarter revenues is currently pegged at $101.4 million indicating year-over-year decline of 19%. Moreover, the consensus mark for earnings has been steady at 24 cents over the past seven days.
Let’s see how things are shaping up prior to this announcement.
IMAX Corporation Price and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
IMAX Corporation (IMAX - Free Report) is set to report fourth-quarter 2018 results on Feb 26.
Notably, the company’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, delivering average positive surprise of 34.6%. In the last reported quarter, the company’s adjusted earnings outpaced the Zacks Consensus Estimate by 3 cents.
Moreover, IMAX’s top line beat the consensus mark in three of the trailing four quarters. In third-quarter 2018, revenues came in at $82.1 million, beating the Zacks Consensus Estimate of $80 million. However, revenues declined 16.9% from the year-ago quarter.
The Zacks Consensus Estimate for fourth-quarter revenues is currently pegged at $101.4 million indicating year-over-year decline of 19%. Moreover, the consensus mark for earnings has been steady at 24 cents over the past seven days.
Let’s see how things are shaping up prior to this announcement.
IMAX Corporation Price and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on T - FREE
Get the latest research report on DIS - FREE
Get the latest research report on IMAX - FREE